Safety Studies

Viopatch is formulated with a skin friendly adhesive that does not cause any irritation or untoward reaction. The above has been validated through extensive clinical trials.

In a 50 day study, Viopatch was administered to 142 patients suffering from musculoskeletal pain and the results were measured in terms of feedback of the patients towards relief from pain, reduction in swelling and inflammation and skin irritation (if any).

The patch had no skin irritation or oedema on any of the patients. The Pain Assessment Scale from National Initiative on Pain Control (NIPC) was used to assess the severity of pain experienced by the patients in the study. 95% of the patients reported a significant reduction in pain levels and 88% of the patients reported reduction in swelling and inflammation.

safety-studies